Minor Autohemotherapy in the Treatment of Acne Vulgar

Abstract

Introduction: Acne is a common inflammatory disease in adolescents and young adults that affects the pilosebaceous unit. Its etiology is multifactorial, and lesion polymorphism characterizes this condition.

Objective: To evaluate the results of treatment with autohemotherapy in patients with acne vulgaris at the Celia Sánchez Manduley Hospital.

Methods: An experimental therapeutic intervention study evaluated the results of minor autohemotherapy in patients with acne vulgaris at the Celia Sánchez Manduley Hospital in Manzanillo, Granma, from January 2020 to May 2022. The study population consisted of 91 patients over 15 years of age, and the sample included 79 patients who met the inclusion criteria.

Results: Females predominated (51.9%), and ages 15 to 19 years contributed the highest number of cases (39.2%). Minor autohemotherapy improved 70.9% of patients. Furthermore, 97.5% of patients had no adverse reactions to this treatment.

Conclusions: Acne vulgaris is a very common inflammatory disease in both women and men. This condition appears most frequently in adolescent patients, with the moderate clinical form being the most common at these ages. Minor autohemotherapy is an alternative treatment method for patient cure and improvement, as it causes few adverse effects and prevents acne recurrence.